The US Food and Drug Administration (FDA) has expanded approval of lumateperone (Caplyta) to include treatment of adults with depressive episodes associated with bipolar I and II disorder, as ...

The approval was supported by data from two phase 3 studies that evaluated Caplyta as monotherapy and adjunctive therapy with lithium or valproate in adults with bipolar depression. The Food and Drug ...

Dr. Harold Koenig answers the question: 'What Is Depression?' — -- Question: What is the difference between depression and manic depression (bipolar disorder)? Answer: Depression and manic ...

A presentation at the 2022 Neuroscience Education Institute (NEI) Congress focused on bipolar depression across the lifespan of the patient, the impact of an early and correct diagnosis on treatment, ...

Researchers from the Indiana University School of Medicine are one step closer to an objective clinical blood test for mood disorders. A robust new study is describing the development of a panel of ...

If you have bipolar I, you likely know how exhausting its highs and lows can be. In a depressive period, you might feel so down that you don’t want to do things you normally enjoy, or even leave your ...

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug ...

Laughing gas (nitrous oxide) appears to offer rapid mood improvement for people with severe or treatment-resistant depression ...